| Reference |
Sentence |
Publish Date |
Extraction Date |
Species |
| Nat\\xc3\\xa1lia Lopes Reinecke, Thulio Marquez Cunha, Ita Pfeferman Heilberg, Elisa Mieko Suemitsu Higa, Jos\\xc3\\xa9 Luiz Nishiura, Jos\\xc3\\xa9 Alberto Neder, Waldemar Silva Almeida, Nestor Scho. Exercise capacity in polycystic kidney disease. American journal of kidney diseases : the official journal of the National Kidney Foundation vol 64 issue 2 2014 24787761 |
we aimed to evaluate exercise capacity and levels of nitric oxide and asymmetric dimethylarginine (adma) in normotensive patients with adpkd. |
2014-09-22 |
2023-01-25 |
Not clear |
| Hideyuki Hyogo, Sho-Ichi Yamagishi, Sayaka Maeda, Kei Fukami, Seiji Ueda, Seiya Okuda, Takashi Nakahara, Yuki Kimura, Tomokazu Ishitobi, Kazuaki Chayam. Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients. Clinical and experimental medicine vol 14 issue 1 2014 23179302 |
although impaired synthesis and/or bioavailability of nitric oxide are considered to contribute to insulin resistance and the progression of liver disease in nonalcoholic fatty liver disease, role of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, has not been examined. |
2014-09-17 |
2023-01-25 |
human |
| Masao Abe, Shinichiro Ochi, Yoko Mori, Kiyohiro Yamazaki, Takashi Ishimaru, Yuta Yoshino, Ryuji Fukuhara, Satoshi Tanimukai, Seiji Matsuda, Shu-Ichi Uen. Distribution of D-3-aminoisobutyrate-pyruvate aminotransferase in the rat brain. BMC neuroscience vol 15 issue 2014 24766736 |
recently, d-aib at was reported to metabolize asymmetric dimethylarginine (adma) in vivo and was suggested to be an important enzyme for nitric oxide metabolism because adma is a competitive inhibitor for nitric oxide synthase. |
2014-08-27 |
2023-01-25 |
rat |
| Saskia J H Brinkmann, Myrte C de Boer, Nikki Buijs, Paul A M van Leeuwe. Asymmetric dimethylarginine and critical illness. Current opinion in clinical nutrition and metabolic care vol 17 issue 1 2014 24281375 |
asymmetric dimethylarginine (adma) is an analog of arginine and functions as an endogenous inhibitor of the nitric oxide synthase, which forms nitric oxide. |
2014-08-01 |
2023-01-25 |
Not clear |
| Kristen A Baltgalvis, Kathy White, Wei Li, Mark D Claypool, Wayne Lang, Raniel Alcantara, Baljit K Singh, Annabelle M Friera, John McLaughlin, Derek Hansen, Kelly McCaughey, Henry Nguyen, Ira J Smith, Guillermo Godinez, Simon J Shaw, Dane Goff, Rajinder Singh, Vadim Markovtsov, Tian-Qiang Sun, Yonchu Jenkins, Gerald Uy, Yingwu Li, Alison Pan, Tarikere Gururaja, David Lau, Gary Park, Yasumichi Hitoshi, Donald G Payan, Todd M Kinsell. Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice. American journal of physiology. Heart and circulatory physiology vol 306 issue 8 2014 24561866 |
these functional performance benefits were accompanied by improved mitochondrial function, the normalization of perfusion in exercising muscle, increased nitric oxide bioavailability, and decreased circulating levels of the endogenous endothelial nitric oxide synthase inhibitor asymmetric dimethylarginine. |
2014-06-15 |
2023-01-25 |
mouse |
| Seiji Maeda, Asako Miyaki, Hiroshi Kumagai, Miki Eto, Rina So, Kiyoji Tanaka, Ryuichi Ajisak. Lifestyle modification decreases arterial stiffness and plasma asymmetric dimethylarginine level in overweight and obese men. Coronary artery disease vol 24 issue 7 2014 23881175 |
asymmetric dimethylarginine (adma) is an endogenous inhibitor of nitric oxide synthase, an enzyme responsible for the generation of nitric oxide. |
2014-05-16 |
2023-01-25 |
Not clear |
| V Vasilev, J Matrozova, A Elenkova, S Vandeva, G Kirilov, S Zachariev. Asymmetric dimethylarginine (ADMA) and soluble vascular cell adhesion molecule 1(sVCAM-1) as circulating markers for endothelial dysfunction in patients with pheochromocytoma. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association vol 121 issue 9 2014 24002898 |
the endogenous inhibitor of nitric oxide syntase, asymmetric dimethylarginine (adma), and soluble adhesion molecules such as vascular cell adhesion molecule 1 (svcam-1) have been established as markers of endothelial dysfunction in a number of pathologic conditions including essential hypertension. |
2014-05-15 |
2023-01-25 |
Not clear |
| Olga Kruszelnicka, Andrzej Surdacki, Alain Gola. Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study. Cardiovascular diabetology vol 12 issue 2014 24103320 |
asymmetric dimethylarginine (adma), an endogenous nitric oxide synthesis inhibitor, and insulin resistance (ir) have been implicated in atherogenesis. |
2014-05-07 |
2023-01-25 |
Not clear |
| M B P Landim, P M M Dourado, A Casella-Filho, A C P Chagas, P L da-Lu. High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas vol 46 issue 5 2014 23681289 |
a low concentration of nitric oxide associated with a high concentration of asymmetric dimethylarginine (adma) can explain the lack of ischemic cardioprotection observed in the presence of hypercholesterolemia. |
2014-03-31 |
2023-01-25 |
rat |
| Ismail Sari, Yusuf Ziya Igci, Gercek Can, Ali Taylan, Dilek Solmaz, Bulent Gogebakan, Servet Akar, Zeynep Eslik, Giray Bozkaya, Nurullah Akko. Is there a relationship between endothelial nitric oxide synthase gene polymorphisms and ankylosing spondylitis? Clinics (Sao Paulo, Brazil) vol 68 issue 3 2014 23644848 |
because candidate genes responsible for susceptibility to ankylosing spondylitis are mostly unknown and available data suggest that there may be problems related to the nitric oxide pathway, such as endothelial dysfunction and increased asymmetric dimethylarginine, this study aimed to assess the association of common endothelial nitric oxide synthase gene polymorphisms with ankylosing spondylitis. |
2014-01-13 |
2023-01-25 |
Not clear |
| Olga Kruszelnicka, Tomasz Rakowski, Andrzej Surdack. Comment on: Tessari et al. Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. Diabetes 2013;62:2699-2708. Diabetes vol 62 issue 10 2013 24065801 |
roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. |
2013-12-10 |
2023-01-25 |
Not clear |
| Paolo Tessar. Response to comment on: Tessari et al. Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. Diabetes 2013;62:2699-2708. Diabetes vol 62 issue 10 2013 24065802 |
roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. |
2013-12-10 |
2023-01-25 |
Not clear |
| Andrzej Surdacki, Olga Kruszelnicka, Tomasz Rakowski, Aleksandra Ja\\xc5\\xbawi\\xc5\\x84ska-Kozuba, Jacek S Dubie. Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study. Cardiovascular diabetology vol 12 issue 2013 23578341 |
our aim was to test the hypothesis that asymmetric dimethylarginine (adma), an endogenous inhibitor of nitric oxide formation, might be linked to future deterioration in glucose tolerance in stable coronary artery disease (cad). |
2013-11-26 |
2023-01-25 |
Not clear |
| Alpaslan Taner, Ali Unlu, Mehmet Kayrak, Mehmet Tekinalp, Selim S Ayhan, Alpay Ar\\xc4\\xb1ba\\xc5\\x9f, Said Sami Erde. The value of serum asymmetric dimethylarginine levels for the determination of masked hypertension in patients with diabetes mellitus. Atherosclerosis vol 228 issue 2 2013 23540293 |
asymmetric dimethylarginine (adma) is an endogenous nitric oxide inhibitor and higher plasma levels of adma are related to increased cv risk in both the general population and among patients with dm. |
2013-10-21 |
2023-01-25 |
Not clear |
| Marjan Noorbakhsh, Maryam Kianpour, Mehdi Nematbakhs. Serum levels of asymmetric dimethylarginine, vascular endothelial growth factor, and nitric oxide metabolite levels in preeclampsia patients. ISRN obstetrics and gynecology vol 2013 issue 2013 24109515 |
serum levels of asymmetric dimethylarginine, vascular endothelial growth factor, and nitric oxide metabolite levels in preeclampsia patients. |
2013-10-10 |
2023-01-25 |
Not clear |
| Paolo Tessari, Diego Cecchet, Carlo Artusi, Monica Vettore, Renato Millioni, Mario Plebani, Lucia Puricelli, Monica Vedovat. Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. Diabetes vol 62 issue 8 2013 23474488 |
roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. |
2013-10-01 |
2023-01-25 |
human |
| M Righett. Cardio-renal-anemia syndrome: a link between erythropoietin, dimethylarginine and homocysteine. Current medicinal chemistry vol 19 issue 21 2013 22680636 |
many studies have shown that erythropoietin improves endothelial function in animals with high dimethylarginine levels, lowering asymmetric dimethylarginine and increasing nitric oxide synthesis. |
2013-08-02 |
2023-01-25 |
Not clear |
| Peter Chedraui, Emilio J Solis, Guido Bocci, Santhosh Gopal, Eleonora Russo, Gustavo S Escobar, Luis Hidalgo, Faustino R P\\xc3\\xa9rez-L\\xc3\\xb3pez, Andrea R Genazzani, Paolo Mannella, Tommaso Simoncin. Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians vol 26 issue 3 2013 23039092 |
feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (vegf) levels and vegf gene polymorphisms in severe preeclampsia. |
2013-07-17 |
2023-01-25 |
Not clear |
| Habil Yucel, Mehmet Ozaydin, Abdullah Dogan, Dogan Erdogan, Yasin Turker, Betul Mermi Ceyhan, Recep Sutc. Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow. Scandinavian journal of clinical and laboratory investigation vol 72 issue 6 2013 22950626 |
plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow. |
2013-06-27 |
2023-01-25 |
Not clear |
| Habil Yucel, Mehmet Ozaydin, Abdullah Dogan, Dogan Erdogan, Yasin Turker, Betul Mermi Ceyhan, Recep Sutc. Plasma concentrations of asymmetric dimethylarginine, nitric oxide and homocysteine in patients with slow coronary flow. Scandinavian journal of clinical and laboratory investigation vol 72 issue 6 2013 22950626 |
asymmetric dimethylarginine (adma), an endogenous inhibitor of nitric oxide synthesis, levels are associated with an increased risk of endothelial dysfunction and atherosclerosis. |
2013-06-27 |
2023-01-25 |
Not clear |